Finanzaonline.com – 28.8.12/09:10
Astrazeneca ha nominato Pascal Soriot, ex direttore finanziario di Roche, come amministratore delegato del gruppo. Soriot, 53 anni, assumerà la carica nella società biofarmaceutica inglese a partire dal primo di ottobre, prendendo il posto lasciato a giugno da David Brennan. L’amministratore delegato ad interim, Simon Lowth, riprenderà il suo incarico di direttore finanziario di Astrazeneca.
Fonte: Finanza.com
AstraZeneca Names Roche’s Pascal Soriot as CEO
AstraZeneca Plc (AZN) named Pascal Soriot, Roche Holding AG’s (ROG) head of pharmaceuticals, as chief executive officer to revive sales and product development as the U.K. company faces one of the industry’s biggest patent expirations.
AstraZeneca Names Roche’s Soriot as CEO as Patent Expiries Loom
Tim Shaffer/Bloomber
Soriot joins the London-based drugmaker as it searches for licensing deals, partnerships and acquisitions of late-stage assets to replenish the pipeline and boost sales.
Soriot joins the London-based drugmaker as it searches for licensing deals, partnerships and acquisitions of late-stage assets to replenish the pipeline and boost sales. Photographer: Tim Shaffer/Bloomberg
Soriot, 53, will join AstraZeneca on Oct. 1, th
